Does XGEVA Cause Malignant neoplasm progression? 11 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Malignant neoplasm progression have been filed in association with XGEVA. This represents 1.1% of all adverse event reports for XGEVA.
11
Reports of Malignant neoplasm progression with XGEVA
1.1%
of all XGEVA reports
6
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From XGEVA?
Of the 11 reports, 6 (54.5%) resulted in death, 2 (18.2%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for XGEVA. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does XGEVA Cause?
Death (309)
Osteonecrosis of jaw (159)
Investigation (115)
Hospitalisation (77)
Hypocalcaemia (48)
Metastases to bone (30)
Pain (28)
Pain in extremity (17)
Dyspnoea (16)
Disease progression (15)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)